Peripheral Neuropathy Trial, Recruiting NCT03881930 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT03881930
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a chronic acquired nerve condition that affects the protective covering of the nerves (called demyelinating neuropathy)
  • People aged 18 or older
  • People who are able to walk at least 20 metres indoors on their own, without another person's help (walking aids such as canes or walkers are allowed)
  • People who experience symptoms such as discomfort or difficulty walking due to problems with sensation or feeling in their body
  • People whose condition has been medically stable for at least 2 months, whether or not they are currently receiving treatment
  • People who have given their informed consent to take part

Who may not be able to join:

  • People who cannot walk 20 metres indoors, even with a walking aid, without another person physically helping them
  • People who are currently admitted to a hospital
  • People who are already taking part in another clinical intervention study
  • People who are currently receiving balance rehabilitation that would continue at a different centre or practice during this trial program
  • People who have started or stopped an active treatment for their nerve condition within the last 2 months
  • People who have surgery planned during their time in the trial that would prevent them from completing the rehabilitation program or assessments
  • People who have had recent surgery, particularly a lower limb prosthesis fitted within the last year, or who have equipment that makes certain exercises (such as standing or kneeling positions) unsafe
  • People who have open skin wounds on their feet that would make rehabilitation unsafe
  • People whose balance problems are caused by an inner ear condition or a brain or central nervous system disorder
  • People with a visual disability
  • People with a hearing impairment that would prevent them from hearing and understanding instructions during the program or assessments
  • People who are unable to speak or understand French
  • People who have difficulty with thinking, communication, or understanding that would prevent them from following the trial procedures
  • People who live outside the Paris region (Île-de-France)
  • People who are known to be pregnant
  • People who are not covered by the French social security system, or who are under legal guardianship, curatorship, are incarcerated, or have had their rights removed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bénédicte PANIGOT GUERIN, PT, Assistance Publique - Hôpitaux de Paris

Phone: 01.40.05.41.73

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2019
Est. completion
1 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

U-turn time of realization, in seconds, realized at a comfortable speed measured with accelerometers just after the end of the rehabilitation program

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov